Correlation Between Walker Dunlop and Genmab AS
Can any of the company-specific risk be diversified away by investing in both Walker Dunlop and Genmab AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Walker Dunlop and Genmab AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Walker Dunlop and Genmab AS, you can compare the effects of market volatilities on Walker Dunlop and Genmab AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Walker Dunlop with a short position of Genmab AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Walker Dunlop and Genmab AS.
Diversification Opportunities for Walker Dunlop and Genmab AS
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Walker and Genmab is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Walker Dunlop and Genmab AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genmab AS and Walker Dunlop is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Walker Dunlop are associated (or correlated) with Genmab AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genmab AS has no effect on the direction of Walker Dunlop i.e., Walker Dunlop and Genmab AS go up and down completely randomly.
Pair Corralation between Walker Dunlop and Genmab AS
Allowing for the 90-day total investment horizon Walker Dunlop is expected to generate 0.9 times more return on investment than Genmab AS. However, Walker Dunlop is 1.11 times less risky than Genmab AS. It trades about 0.0 of its potential returns per unit of risk. Genmab AS is currently generating about -0.21 per unit of risk. If you would invest 11,127 in Walker Dunlop on August 30, 2024 and sell it today you would lose (45.00) from holding Walker Dunlop or give up 0.4% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Walker Dunlop vs. Genmab AS
Performance |
| Timeline |
| Walker Dunlop |
| Genmab AS |
Walker Dunlop and Genmab AS Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Walker Dunlop and Genmab AS
The main advantage of trading using opposite Walker Dunlop and Genmab AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Walker Dunlop position performs unexpectedly, Genmab AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genmab AS will offset losses from the drop in Genmab AS's long position.| Walker Dunlop vs. Velocity Financial Llc | Walker Dunlop vs. Security National Financial | Walker Dunlop vs. Encore Capital Group | Walker Dunlop vs. PennyMac Finl Svcs |
| Genmab AS vs. Ascendis Pharma AS | Genmab AS vs. Apellis Pharmaceuticals | Genmab AS vs. BeiGene | Genmab AS vs. Akero Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |